Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INTRINSIC Trial: Tranexamic Acid in Spontaneous Intracerebral Haemorrhage
NCT05836831Phase 4Recruiting
- Sponsor
- Christian Medical College, Vellore
- Start
- Aug 2022
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in intracerebral hemorrhage (ICH) (2 arms), sponsored by Christian Medical College, Vellore. Primary endpoint: Death at 30 days. Started Aug 2022; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT05836831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05836831.